skip to Main Content

HOME

Meet the Future of Life Science

GALLERY

MEDIA

NOTICE

C&R Healthcare Global

ASEAN K-beauty market trend review under COVID-19 and tips for business expansion in the new normal

ASEAN K-beauty market trend review under COVID-19 and tips for business expansion in the new normal

Singapore’s beauty market is saturated with countless brands from globe. Nevertheless, K-beauty products continuously gain…

read more
KO’SCOS performance in 2020 and business plan in 2021

KO’SCOS performance in 2020 and business plan in 2021

KO’SCOS, the K-beauty project supported by KHIDI (Korea Health Industry Development Institute) and managed by…

read more
C&R Healthcare Global, Singapore National University Hospital Innovation Center, China, Taiwan, and Australia connected ASIA RESEARCH & INNOVATION ALLIANCE with MoU as Korea representative

C&R Healthcare Global, Singapore National University Hospital Innovation Center, China, Taiwan, and Australia connected ASIA RESEARCH & INNOVATION ALLIANCE with MoU as Korea representative

C&R Healthcare Global (as C&R HG) is an ASIA RESEARCH & INNOVATION ALLIANCE connecting Singapore-China-Australia…

read more
C&R Healthcare Global, despite the Covid-19 situation, spurs new business operations such as 2020 sales growth of 154.5% compared to the previous year and project orders for global pharmaceutical companies in the fourth quarter

C&R Healthcare Global, despite the Covid-19 situation, spurs new business operations such as 2020 sales growth of 154.5% compared to the previous year and project orders for global pharmaceutical companies in the fourth quarter

C&R Healthcare Global (as C&R HG) announced in its 2020 business report published in mid-December…

read more

Innovators

GE Healthcare-Humanscape, MOU to Revitalize Obstetrics and Gynecology Market

GE Healthcare-Humanscape, MOU to Revitalize Obstetrics and Gynecology Market

GE Healthcare Korea (CEO Kang Sung-wook) and Humanscape (CEO Jang Min-hoo) announced on the 4th…

read more
MOU for establishment of data platform for people with rare diseases, Humanscape-Pompe’s disease patients

MOU for establishment of data platform for people with rare diseases, Humanscape-Pompe’s disease patients

Humanscape, which is developing a blockchain-based data platform for patients with rare, incurable diseases, signed…

read more
Humanscape launched Rarenote, a customized platform for rare diseases

Humanscape launched Rarenote, a customized platform for rare diseases

Humanscape, a member company of C&R Healthcare Global (C&R HG), has launched 'Rarenote', a custom…

read more
GC Cell achieved a breaking-record result of its “Immuncell-LC” product, reaching accumulative sales of 26.7 billion won for the first three quarters of 2019

GC Cell achieved a breaking-record result of its “Immuncell-LC” product, reaching accumulative sales of 26.7 billion won for the first three quarters of 2019

GC Cell achieved 26.7 billion won (31.1M SGD) in accumulative sales in the third quarter…

read more
Back To Top